Abstract:Cell-intrinsic reporters such as luciferase (LUC) and red fluorescent protein (RFP) have been commonly utilized in preclinical studies to image tumor growth and to monitor therapeutic responses. While extrinsic reporters that emit near infrared I (NIR-I: 650-950 nm) or near-infrared II (NIR-II: 1000 -1700 nm) optical signals have enabled minimization of tissue autofluorescence and light scattering, it has remained unclear as to whether their use has afforded more accurate tumor imaging in small animals. Here, we developed a novel optical imaging construct comprised of rare earth lanthanide nanoparticles coated with biodegradable diblock copolymers and doped with organic fluorophores, generating NIR-I and NIR-II emissive bands upon optical excitation. Simultaneous injection of multiple spectrally-unique nanoparticles into mice bearing tumor implants established via intraperitoneal dissemination of LUC+/ RFP+ OVCAR-8 ovarian cancer cells enabled direct comparisons of imaging with extrinsic vs. intrinsic reporters, NIR-II vs. NIR-I signals, as well as targeted vs. untargeted exogenous contrast agents in the same animal and over time. We discovered that in vivo optical imaging at NIR-II wavelengths facilitates more accurate detection of smaller and earlier tumor deposits, offering enhanced sensitivity, improved spatial contrast, and increased depths of tissue penetration as compared to imaging with visible or NIR-I fluorescent agents. Our work further highlights the hitherto underappreciated enhancements in tumor accumulation that may be achieved with intraperitoneal as opposed to intravenous administration of nanoparticles. Lastly, we found discrepancies in the fidelity of tumor uptake that could be obtained by utilizing small molecules for in vivo as opposed to in vitro targeting of nanoparticles to disseminated tumors. (C) 2017 Elsevier Ltd. All rights reserved.

Aggregation-induced emission dots assisted non-invasive fluorescence hysterography in near-infrared IIb window

Early Tumor Detection Afforded by in Vivo Imaging of Near-Infrared Ii Fluorescence

Photostable Fluorescent Organic Dots with Aggregation-Induced Emission (aie Dots) for Noninvasive Long-Term Cell Tracing

Aggregation‐induced Emission Luminogens for in Vivo Molecular Imaging and Theranostics in Cancer

Biocompatible organic dots with aggregation-induced emission for in vitro and in vivo fluorescence imaging

NIR-II fluorescence/photoacoustic imaging of ovarian cancer and peritoneal metastasis

Biologically Excretable Aggregation‐Induced Emission Dots for Visualizing Through the Marmosets Intravitally: Horizons in Future Clinical Nanomedicine

Aggregation‐induced Emission Based Fluorogens for Mitochondria‐targeted Tumor Imaging and Theranostics

Near-Infrared Fluorescent Agent for In Vitro Screening of Endometrial Cancer and Precancerous Lesions

Aggregation-induced red-NIR emission organic nanoparticles as effective and photostable fluorescent probes for bioimaging

Real-Time and High-Resolution Bioimaging with Bright Aggregation-Induced Emission Dots in Short-Wave Infrared Region

Recent advances of aggregation-induced emission materials for fluorescence image-guided surgery

Detecting benign uterine tumors by autofluorescence lifetime imaging microscopy through adjacent healthy cervical tissues

Ultrabright NIR‐II Emissive Polymer Dots for Metastatic Ovarian Cancer Detection

Non-invasive evaluation of endometrial microvessels via in vivo intrauterine photoacoustic endoscopy

Utilization of aggregation‐induced emission materials in urinary system diseases

Tuning Molecular Aggregation to Achieve Highly Bright AIE Dots for NIR-II Fluorescence Imaging and NIR-I Photoacoustic Imaging

Polymeric Engineering of AIEgens for NIR-II Fluorescence Imaging and Detection of Abdominal Metastases of Ovarian Cancer in Vivo.

Bright and Photostable Organic Fluorescent Dots with Aggregation‐Induced Emission Characteristics for Noninvasive Long‐Term Cell Imaging

Aggregation-induced Emission Luminogen for Specific Identification of Malignant Tumour in Vivo

Pre-clinical study of IR808 dye for cervical cancer in vitro and in vivo imaging